ACET Jul 2024 2.500 put
| Previous Close | 0.8000 |
| Open | 0.8000 |
| Bid | 0.0000 |
| Ask | 1.5500 |
| Strike | 2.50 |
| Expire Date | 2024-07-19 |
| Day's Range | 0.8000 - 0.8000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 18 |
Simply Wall St.We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Business Wire
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
REDWOOD CITY, Calif. & BOSTON, June 05, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-001 for the potential treatment of relapsed/refractory class III or class IV lupus nephritis.
Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif. & BOSTON, May 31, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on May 31, 2024.
